β-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction
Bingyuan Bao(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Mamoru Hayano(Hyogo Medical University), Satoshi Shizuta(Kyoto University), Junichi Tazaki(Hyogo Medical University), Yutaka Furukawa(Kobe City Medical Center General Hospital), Hiroki Shiomi(Kyoto University), Masashi Iwabuchi(Kindai University Hospital), Kazuaki Mitsudo(Kurashiki Central Hospital), Kazushige Kadota(Kurashiki Central Hospital), Hisayoshi Fujiwara(Hyogo Prefectural Amagasaki General Medical Center), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Masahiro Natsuaki(Saga University), Masakiyo Nobuyoshi(Kurume University), Toru Kita(Hyogo Medical University), Neiko Ozasa(Kyoto University), Tomohisa Tada(Shizuoka General Hospital), Yoshihiro Kato(Hyogo Medical University)
Cited by 34
Related Papers
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359